Literature DB >> 3857621

Intron-mediated recombination may cause a deletion in an alpha 1 type I collagen chain in a lethal form of osteogenesis imperfecta.

G S Barsh, C L Roush, J Bonadio, P H Byers, R E Gelinas.   

Abstract

To understand the nature of the mutation in type I collagen genes in cells from an infant with the perinatal lethal form of osteogenesis imperfecta (type II), we cloned and sequenced almost 2 kilobases of a normal alpha 1(I) collagen gene and the corresponding region of a mutant alpha 1(I) gene from cell strain CRL 1262. The mutant gene had undergone recombination between two non-homologous introns, which resulted in the loss of three exons coding for 84 amino acids in the triple-helical domain. The deletion predicted the loss of amino acid residues surrounding and including the methionine at the junction between the CNBr peptides alpha 1(I) CB8 and alpha 1(I) CB3, a result confirmed by analysis of the cleavage peptides from the product of the mutant gene. Although large deletions from collagen genes are uncommon causes of the osteogenesis imperfecta type II phenotype, analysis of the de novo change in gene structure in this cell strain suggests that similar rearrangements may have occurred during the evolution of the large collagen genes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3857621      PMCID: PMC397668          DOI: 10.1073/pnas.82.9.2870

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta.

Authors:  M L Chu; C J Williams; G Pepe; J L Hirsch; D J Prockop; F Ramirez
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

2.  A high speed, high capacity homology matrix: zooming through SV40 and polyoma.

Authors:  J Pustell; F C Kafatos
Journal:  Nucleic Acids Res       Date:  1982-08-11       Impact factor: 16.971

3.  DNA sequence analysis of a mouse pro alpha 1 (I) procollagen gene: evidence for a mouse B1 element within the gene.

Authors:  J M Monson; J Friedman; B J McCarthy
Journal:  Mol Cell Biol       Date:  1982-11       Impact factor: 4.272

4.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.

Authors:  J Vieira; J Messing
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

5.  The human growth hormone gene family: structure and evolution of the chromosomal locus.

Authors:  G S Barsh; P H Seeburg; R E Gelinas
Journal:  Nucleic Acids Res       Date:  1983-06-25       Impact factor: 16.971

6.  Procollagen genes: further sequence studies and interspecies comparisons.

Authors:  V Tate; M Finer; H Boedtker; P Doty
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1983

7.  Synthesis of a shortened pro-alpha 2(I) chain and decreased synthesis of pro-alpha 2(I) chains in a proband with osteogenesis imperfecta.

Authors:  W J de Wet; T Pihlajaniemi; J Myers; T E Kelly; D J Prockop
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

Review 8.  Repetitive sequences in eukaryotic DNA and their expression.

Authors:  W R Jelinek; C W Schmid
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

9.  A history of the human fetal globin gene duplication.

Authors:  S H Shen; J L Slightom; O Smithies
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

10.  Synthesis and processing of a type I procollagen containing shortened pro-alpha 1(I) chains by fibroblasts from a patient with osteogenesis imperfecta.

Authors:  C J Williams; D J Prockop
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

View more
  32 in total

1.  Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta.

Authors:  T Pihlajaniemi; J McKeon; S Gay; R Gay; W J de Wet; J C Myers; D J Prockop
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

2.  The molecular defect in a family with mild atypical osteogenesis imperfecta and extreme joint hypermobility: exon skipping caused by an 11-bp deletion from an intron in one COL1A2 allele.

Authors:  A C Nicholls; J Oliver; D V Renouf; D A Heath; F M Pope
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

3.  Short DNA fragments induce site specific recombination in mammalian cells.

Authors:  K Hunger-Bertling; P Harrer; W Bertling
Journal:  Mol Cell Biochem       Date:  1990-02-09       Impact factor: 3.396

4.  The human type I collagen mutation database.

Authors:  R Dalgleish
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

5.  Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.

Authors:  P H Byers; P Tsipouras; J F Bonadio; B J Starman; R C Schwartz
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

6.  Assessment of small polymorphisms in defined human collagen gene segments.

Authors:  M Sippola-Thiele; G C Tromp; D J Prockop; F Ramirez
Journal:  Hum Genet       Date:  1986-03       Impact factor: 4.132

7.  Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.

Authors:  D H Cohn; P H Byers; B Steinmann; R E Gelinas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 8.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

Review 9.  Perinatal lethal osteogenesis imperfecta.

Authors:  W G Cole; R Dalgleish
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

10.  Induction, by thymidylate stress, of genetic recombination as evidenced by deletion of a transferred genetic marker in mouse FM3A cells.

Authors:  D Ayusawa; H Koyama; K Shimizu; S Kaneda; K Takeishi; T Seno
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.